TRT dosing claims: what the 'fuel for your engine' framing gets wrong

What did @socalurologyinstitute actually say?

The creator laid out a testosterone dosing formula that goes like this: your bodyweight in pounds equals your weekly milligram dose. "You're 200 pounds, you need 200 milligrams. You're 100 pounds, take 100 milligrams." They also argued that activity level should drive dose adjustments up or down, with exercise burning through testosterone like a car burns fuel. The engine-and-fuel analogy runs through the entire video.

To be fair, the creator does make a real clinical observation buried in the middle: patients who suddenly become sedentary after an injury can show unexpectedly high serum testosterone on a previously stable dose. That part reflects something real. The problem is the framework they built around it.

Does the science back this up?

Not really, no. The weight-equals-dose formula has no basis in published endocrinology guidelines, and the activity-level-as-primary-driver claim is a significant oversimplification of how testosterone pharmacokinetics actually work.

The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend initiating testosterone cypionate or enanthate at 75-100 mg weekly or 150-200 mg every two weeks, then titrating based on serum testosterone levels, symptom response, and hematocrit monitoring. Body weight is not listed as a primary dosing variable. Neither is exercise volume.

Research on testosterone pharmacokinetics does show that lean body mass and androgen receptor density influence how testosterone is utilized at the tissue level (Sinha-Hikim et al., 2002, Journal of Clinical Endocrinology and Metabolism), but that is not the same as saying heavier people need proportionally more exogenous testosterone. A 200-pound man with primary hypogonadism and a 200-pound man with secondary hypogonadism will respond very differently to the same dose.

What did they get wrong (or right)?

The weight-based formula is wrong, and it is the kind of wrong that could actually harm someone. A 200-pound patient on 200 mg weekly of testosterone cypionate without baseline labs, hematocrit monitoring, or estradiol checks is a patient at elevated risk for erythrocytosis, cardiovascular strain, and estrogenic side effects. The Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine) specifically documented the importance of individualized dosing and monitoring in older men, finding that even modest supraphysiologic levels increased cardiovascular risk signals.

What the creator got partially right is the clinical observation that increased physical activity can correlate with lower serum testosterone readings on a stable dose. There is some mechanistic plausibility here: exercise transiently increases androgen receptor expression and testosterone uptake in muscle tissue (Kraemer and Ratamess, 2005, Sports Medicine). But "take more testosterone" is not the medically appropriate response to a low serum reading without a full clinical workup. It could also reflect injection technique issues, storage problems, or assay variability.

• Wrong: bodyweight in pounds directly equals milligram dose
• Wrong: activity level alone should drive self-directed dose changes
• Partially right: sedentary periods can push serum levels higher on a fixed dose
• Missing entirely: hematocrit, PSA, estradiol, and symptom monitoring

What should you actually know?

TRT dosing is individualized, laboratory-driven, and monitored over time. Full stop. A legitimate TRT protocol involves a baseline total testosterone, free testosterone, LH, FSH, hematocrit, PSA, and metabolic panel before a single milligram is prescribed. Dose titration happens based on where your serum levels land relative to the mid-normal physiologic range, which the Endocrine Society defines as approximately 400-700 ng/dL for most adult men.

The "fuel for the engine" framing is catchy but medically imprecise in ways that matter. Testosterone is not simply consumed by activity like gasoline. It is metabolized hepatically and peripherally, aromatized to estradiol, and bound by sex hormone-binding globulin at rates that vary by individual genetics, body composition, age, and comorbidities (Vermeulen et al., 1999, Journal of Clinical Endocrinology and Metabolism).

If you are on TRT and your levels have shifted significantly, the right move is a clinical conversation with your prescriber, not a unilateral dose increase. Supraphysiologic testosterone levels, even brief ones, are associated with elevated hematocrit and potential cardiovascular risk. Monitoring is not optional.